345 related articles for article (PubMed ID: 17675057)
1. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
Frantz RP; Olson LJ; Grill D; Moualla SK; Nelson SM; Nobrega TP; Hanna RD; Backes RJ; Mookadam F; Heublein D; Bailey KR; Burnett JC
Am Heart J; 2005 Mar; 149(3):541-7. PubMed ID: 15864245
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
[TBL] [Abstract][Full Text] [Related]
5. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
6. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
[TBL] [Abstract][Full Text] [Related]
7. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial.
Bristow MR; Krause-Steinrauf H; Nuzzo R; Liang CS; Lindenfeld J; Lowes BD; Hattler B; Abraham WT; Olson L; Krueger S; Thaneemit-Chen S; Hare JM; Loeb HS; Domanski MJ; Eichhorn EJ; Zelis R; Lavori P
Circulation; 2004 Sep; 110(11):1437-42. PubMed ID: 15337700
[TBL] [Abstract][Full Text] [Related]
8. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
Gwechenberger M; Hülsmann M; Berger R; Graf S; Springer C; Stanek B; Pacher R
J Heart Lung Transplant; 2004 Jul; 23(7):839-44. PubMed ID: 15261178
[TBL] [Abstract][Full Text] [Related]
11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
12. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
Jourdain P; Jondeau G; Funck F; Gueffet P; Le Helloco A; Donal E; Aupetit JF; Aumont MC; Galinier M; Eicher JC; Cohen-Solal A; Juillière Y
J Am Coll Cardiol; 2007 Apr; 49(16):1733-9. PubMed ID: 17448376
[TBL] [Abstract][Full Text] [Related]
13. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
Berger R; Huelsmann M; Strecker K; Moertl D; Moser P; Bojic A; Pacher R
Eur J Clin Invest; 2005 Jan; 35(1):24-31. PubMed ID: 15638816
[TBL] [Abstract][Full Text] [Related]
14. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
[TBL] [Abstract][Full Text] [Related]
16. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
18. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
Kazanegra R; Cheng V; Garcia A; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
J Card Fail; 2001 Mar; 7(1):21-9. PubMed ID: 11264546
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN;
J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801
[TBL] [Abstract][Full Text] [Related]
20. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]